News|Articles|March 6, 2024
High Resolution Methods for Clinical Biomarker Validation
Author(s)Sannova Analytical
Discover how high-resolution biomarker assays such as Meso Scale Discovery (MSD) and advanced Mass Spectrometry (MS) go beyond the limitations of traditional ELISA assays, and how they overcome central challenges in biomarker assessment and ligand binding assays (LBAs).
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
2
How Programmable Biology Could Reshape Biologic Drug Development
3
Launch in Lockstep: Biopharma Readiness for the CNPV’s Accelerated Clock
4
Ask the Expert: Audits, Inspections, and CDMOs
5
